Skip to content

Kaya Barakat Masson Syndrome C5436856

Published: July 22, 2026Updated: August 20, 2026

A rare genetic neurological condition with variable symptoms affecting development and nervous system function. Treatment is tailored to individual needs and may include various supportive approaches.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(neurologic)

Spasticity

(neurologic)

Dysarthria

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Systematic health surveillance

Regular monitoring of the characteristic features of this syndrome including cardiac, skeletal, and neurological manifestations with appropriate specialist involvement.

monitoring
3

Corrective and reconstructive surgery

Surgical intervention for structural defects when indicated, potentially including cardiac repair, skeletal procedures, or reconstructive operations.

surgical

Additional treatment options

Mobility and function optimization

Therapeutic exercises and interventions to maximize physical function, address mobility limitations, and support independent movement capabilities.

physical_therapy

Cognitive and emotional support services

Neuropsychological evaluation, counseling, and educational support addressing learning challenges, social difficulties, and emotional well-being.

psychological

Adaptive daily living strategies

Implementation of environmental modifications, assistive technologies, and adaptive techniques to support independence in daily activities and quality of life.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Kaya Barakat Masson Syndrome C5436856?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Kaya Barakat Masson Syndrome C5436856. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy